Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05774470 · ClinicalTrials.gov registry record
Bradycardia Recognition and Detection in Young Infants Part-I
A clinical trial of Hypoxemia of Newborn and Neonatal Bradycardia, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- 70
- Enrollment target
- 1
- Study location
NCT05774470: Completed study of Hypoxemia of Newborn and Neonatal Bradycardia, sponsored by University of Alabama at Birmingham.
NCT05774470 is a study of Hypoxemia of Newborn and Neonatal Bradycardia that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 70 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05774470, a study of Hypoxemia of Newborn and Neonatal Bradycardia, has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- 70 participants
- Enrollment target
- 1
- Study location
Study Summary
This prospective cohort study will determine the diagnostic accuracy of the Owlet OSS 3.0 monitor for the detection of episodes of bradycardia and/or hypoxemia among infants.
Primary Outcome
The diagnostic accuracy of the Owlet OSS 3.0 monitor for detection of bradycardia \<50/min and/or hypoxemia with SpO2 \<80% episodes for ≥3 seconds during a 48-hour period.
Conditions Studied
Interventions
- DEVICE Owlet OSS 3.0
Study Locations (1)
Alabama
- UAB Hospital - Birmingham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2023-04-22 |
| Est. Completion | 2023-07-29 |
What the finished NCT05774470 record still lists
NCT05774470 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 70 participants, a relatively small participant target.
The record links to 2 conditions, with Hypoxemia of Newborn appearing as the primary indexed condition, and to 1 intervention - of which Owlet OSS 3.0 is the first listed.
NCT05774470 reports a single indexed study location in Alabama.
Frequently Asked Questions
What is clinical trial NCT05774470 about?
NCT05774470 is a clinical study titled "Bradycardia Recognition and Detection in Young Infants Part-I". This prospective cohort study will determine the diagnostic accuracy of the Owlet OSS 3.0 monitor for the detection of episodes of bradycardia and/or hypoxemia among infants.
What is the current status of trial NCT05774470?
This trial is currently completed. The enrollment target is 70 participants. The study started on 2023-04-22. Estimated completion is 2023-07-29.
What conditions does trial NCT05774470 study?
This clinical trial studies the following conditions: Hypoxemia of Newborn, Neonatal Bradycardia.
What interventions are being tested in trial NCT05774470?
The interventions under investigation include: Owlet OSS 3.0 (DEVICE).
Who is sponsoring clinical trial NCT05774470?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05774470 being conducted?
This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hypoxemia of Newborn
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00969111 · 70 participants · NA
Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy
- NCT01712620 · 70 participants · Phase 2
Spironolactone for Pulmonary Arterial Hypertension
- NCT02143830 · 70 participants · Phase 2
HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy
- NCT02601339 · 70 participants
NIRS Monitoring in Premature Infants
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI